×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [22]
西安交通大学 [10]
中国医学科学院 北京... [9]
山东大学 [4]
南华大学 [3]
上海药物研究所 [3]
更多...
内容类型
期刊论文 [66]
学位论文 [3]
其他 [1]
发表日期
2019 [12]
2018 [11]
2017 [8]
2016 [8]
2015 [9]
2014 [5]
更多...
学科主题
Endocrinol... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共70条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
作者升序
作者降序
提交时间升序
提交时间降序
题名升序
题名降序
A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer
期刊论文
MOLECULAR CANCER, 2019, 卷号: 18
作者:
Gu, Peng
;
Chen, Xu
;
Xie, Ruihui
;
Xie, Weibin
;
Huang, Li
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2019/12/04
Castration resistance prostate Cancer (CRPC)
lncRNA LBCS
Castration resistance
Androgen receptor (AR)
hnRNPK
A multicenter observational study of the real-world use of docetaxel for metastatic castration-resistant prostate cancer in China
期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 卷号: 15, 期号: 3
作者:
He, Dalin
;
Sun, Zhongquan
;
Guo, Jianming
;
Zhang, Zhigen
;
Shan, Yuxi
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2019/12/05
castration-resistant prostate cancer
docetaxel
observational
Phenotypes of circulating tumour cells predict time to castration resistance in metastatic castration-sensitive prostate cancer
期刊论文
BJU INTERNATIONAL, 2019, 卷号: 124, 期号: 2
作者:
Yang, Yun-Jie
;
Kong, Yun-Yi
;
Li, Gao-Xiang
;
Wang, Yue
;
Ye, Ding-Wei
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
circulating tumour cells
androgen deprivation therapy
castration-sensitive
prognosis
#ADT
#ProstateCancer
#PCSM
Management of patients with advanced prostate cancer in the Asia Pacific region: "real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017
期刊论文
BJU INTERNATIONAL, 2019, 卷号: 123, 期号: 1
作者:
Chiong, Edmund
;
Murphy, Declan G.
;
Akaza, Hideyuki
;
Buchan, Nicholas C.
;
Chung, Byung Ha
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/05
advanced prostate cancer
castration-naive prostate cancer
castration-resistant prostate cancer
high-risk localised prostate cancer
oligometastatic prostate cancer
cost and access to treatment
Clinical activity of abiraterone plus prednisone in docetaxel-naive and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer
期刊论文
ASIAN JOURNAL OF ANDROLOGY, 2019, 卷号: 21, 期号: 2
作者:
Lin, Guo-Wen
;
Li, Gao-Xiang
;
Dai, Bo
;
Ye, Ding-Wei
;
Kong, Yun-Yi
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/05
abiraterone acetate
castration-resistant prostate cancer
clinical activity
docetaxel-naive
docetaxel-pretreated
Codelivery of miR-4638-5p and Docetaxel Based on Redox-Sensitive Polypeptide Micelles as an Improved Strategy for the Treatment of Castration-Resistant Prostate Cancer
期刊论文
MOLECULAR PHARMACEUTICS, 2019, 卷号: 16, 期号: 1
作者:
Jiang, Wenjun
;
Gao, Yuan
;
Wang, Zhuo
;
Gong, Chunai
;
Hu, Chuling
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/12/05
codelivery
docetaxel
miR-4638-5p
enhanced effect
castration-resistant prostate cancer
4-1BBL has a Possible Role in Mediating Castration-Resistant Conversion of Prostate Cancer via Up-Regulation of Androgen Receptor
期刊论文
JOURNAL OF CANCER, 2019, 卷号: 10, 期号: 11
作者:
Zhu, Hengcheng
;
Wang, Min
;
Du, Yang
;
Liu, Xiuheng
;
Weng, Xiaodong
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/05
4-1BBL
prostate cancer
castration resistant prostate cancer
androgen receptor
Codelivery of miR-4638–5p and Docetaxel Based on Redox-Sensitive Polypeptide Micelles as an Improved Strategy for the Treatment of Castration-Resistant Prostate Cancer
期刊论文
Molecular Pharmaceutics, 2019, 卷号: Vol.16 No.1, 页码: 437-447
作者:
Wenjun Jiang
;
Yuan Gao
;
Zhuo Wang
;
Chunai Gong
;
Chuling Hu
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2019/12/13
castration-resistant
prostate
cancer
codelivery
docetaxel
enhanced
effect
miR-4638−5p
First-in-human study of Lu-177-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer
期刊论文
2019, 卷号: 46, 期号: 1, 页码: 148-158
作者:
Zang, Jie
;
Fan, Xinrong
;
Wang, Hao
;
Liu, Qingxing
;
Wang, Jingnan
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2020/01/03
Radioligand therapy (RLT)
Lu-177
Evans blue
Prostate-specific membrane antigen (PSMA)
Metastatic castration-resistant prostate cancer (mCRPC)
Pretherapeutic Ga-68-PSMA-617 PET May Indicate the Dosimetry of Lu-177-PSMA-617 and Lu-177-EB-PSMA-617 in Main Organs and Tumor Lesions
期刊论文
2019, 卷号: 44, 期号: 6, 页码: 431-438
作者:
Wang, Jingnan
;
Zang, Jie
;
Wang, Hao
;
Liu, Qingxing
;
Li, Fang
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2020/01/03
Ga-68
Lu-177
prostate-specific membrane antigen (PSMA)
metastatic castration-resistant prostate cancer (mCRPC)
dosimetry
©版权所有 ©2017 CSpace - Powered by
CSpace